Category: Latest News
-
McFarlane expands Juby Gold Project in Ontario
Interview with Mark Trevisiol, president, CEO, and chair of McFarlane Lake Mining (USOTC:MLMLF) (CSE:MLM). Ricki: Hello, I’m Ricki Lee and this is The Capital Compass. Today we are looking at McFarlane Lake Mining. The Canadian gold exploration company is advancing one of Ontario’s largest undeveloped gold projects, the Juby Gold Project in Abitibi Greenstone Belt near…
-
U.S. Stocks Give Back Ground After Last Week’s Rally
After coming under pressure early in the session, stocks staged a recovery attempt in mid-day trading on Monday but moved back to the downside as the day progressed. The major averages all finished the session firmly in negative territory. The Dow slumped 427.09 points or 0.9 percent to 47,289.33, the Nasdaq fell 89.76 points or…
-
Nvidia Shares in Focus After CEO Frames China as a “Bonus Opportunity”
Nvidia (NASDAQ:NVDA) CEO Jensen Huang said China should be viewed as a “bonus opportunity” for the chipmaker, noting that the company’s immediate priority is satisfying exceptional worldwide demand for its technology. Speaking in an interview with CNBC on Monday, Huang said demand for Nvidia’s products is currently “skyrocketing,” leaving the company fully absorbed in serving…
-
Fusemachines Shares Gain Following New AI Integration Deal with RentRedi
Fusemachines Inc. (NASDAQ:FUSE) advanced 4.9% on Monday after the enterprise AI company unveiled a fresh partnership with RentRedi, a software platform built for property management. Through the agreement, RentRedi will incorporate Fusemachines’ AI Studio for Real Estate into its technology stack, enabling the two firms to co-develop AI-driven tools aimed at helping independent landlords streamline…
-
Rezolve AI Shares Slip Following $90 Million Deal to Acquire Crownpeak
Rezolve AI Ltd (NASDAQ:RZLV) fell 7.5% on Monday after the conversational commerce firm revealed plans to acquire digital experience platform provider Crownpeak in a deal valued at $90 million, along with a sizeable debt load. The transaction — which the company expects to finalize within 48 hours — includes a $90 million purchase price made…
-
Golden Matrix Shares Gain as CEO Prepares 2025 Departure; Chairman to Oversee Transition
Golden Matrix Group Inc (NASDAQ:GMGI) advanced 9.7% on Monday after announcing a planned management transition that will see longtime CEO Brian Goodman step down by December 2025. Chairman William Scott — a seasoned gaming industry executive — will assume the role of Interim CEO and lead the search for a permanent successor. Scott brings extensive…
-
Bally’s Shares Jump After Company Wins Sought-After New York Casino License
Bally’s Corp (NYSE:BALY) saw its stock climb more than 9% in early Monday trading after securing one of the highly contested casino licenses designated for the New York City metropolitan area. The New York State Gaming Commission’s facility location board approved Bally’s plan to develop and operate a casino at a Bronx golf course property…
-
Fitell Shares Skyrocket After Launching $3 Million Buyback Plan
Fitell Corporation (NASDAQ:FTEL) soared 51.8% on Monday after the Australian fitness retailer unveiled a newly approved $3 million share repurchase program. The board’s authorization allows the company to buy back up to $3 million worth of ordinary shares over the next two years. Fitell said it may execute repurchases through open-market transactions, block trades, or…
-
Hudson Technologies Shares Jump After Company Boosts Stock Buyback Program
Hudson Technologies Inc (NASDAQ:HDSN) climbed 7.2% on Monday after the company revealed that it is significantly increasing its share repurchase capacity, reflecting growing confidence in its balance sheet and future growth prospects. The refrigerant services provider said its board has approved a major expansion of the 2025 repurchase authorization, doubling the previously allotted $10 million…
-
Galmed Pharmaceuticals Shares Edge Higher Following CEO’s Positive Update
Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) gained 2.4% on Monday after CEO Allen Baharaff issued a shareholder update outlining the company’s strengthened financial footing and progress across several clinical programs. The biopharmaceutical developer — which has broadened its pipeline beyond liver disease to include oncology and cardiometabolic conditions — ended the third quarter with roughly $19.2 million…